Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session Company to host investor conference call and webcast during EHA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results